About BIOANALYTICAL SERVICES AND TECHNOLOGIES, LLC
Bioanalytical Services and Technologies, LLC performs laboratory analysis using analytical equipment to evaluate serum levels of endogenous inosine and hypoxanthine from hospital emergency department heart patients experiencing chest pain (non-traumatic) and clinical sign/symptoms indicating ACI conditions, prior to having an AMI event. We will clinically validate these candidate biomarkers for indicating acute cardiac ischemia (ACI). These candidate ACI biomarkers can rapidly be measured using our US patented rapid luminescence clinical test to help lower the US and worldwide morbidity and mortality rates from heart attacks and cardiac arrests.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOANALYTICAL SERVICES AND TECHNOLOGIES, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.